Replies to post #233720 on Biotech Values

[DewDiligence]

BLI—The IPO announcement was posted in #msg-156975340.

Is this another Foundation Medicine opportunity?

I don’t think the business models are similar. BRI sells drug-development tools, while FMI (now part of Roche) primarily sells diagnostic services.

BLI’s share price tripled on Friday (the first day of trading), so if you’re inclined to invest it may be sensible to wait for a better entry point.